Loading
IARC estimates 23,246 new cancer cases and 13,676 cancer deaths in Malawi in 2024; the commonest new cancers are cervix uteri, oesophagus and Kaposi sarcoma. This page is assembled automatically from OnCo's data: 1 trial with a site there, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 6,773 | 93.4 | Cervical cancer |
| Oesophagus | 2,642 | 23.2 | Oesophageal cancer |
| Kaposi sarcoma | 2,384 | 13.4 | Kaposi sarcoma |
| Breast | 1,447 | 20.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Non-Hodgkin lymphoma | 1,252 | 6.5 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Bladder | 925 | 7.5 | Bladder & urothelial cancer |
| Prostate | 582 | 16.7 | Prostate cancer |
| Liver and intrahepatic bile ducts | 515 | 3.3 | Hepatocellular carcinoma |
| Colorectum | 413 | 3.8 | Colorectal cancer |
| Stomach | 350 | 3.5 | Gastric & gastro-oesophageal junction cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 3,844 | 55.2 | Cervical cancer |
| Oesophagus | 2,162 | 20.1 | Oesophageal cancer |
| Kaposi sarcoma | 984 | 5.6 | Kaposi sarcoma |
| Breast | 666 | 10.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Non-Hodgkin lymphoma | 589 | 3.3 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Liver and intrahepatic bile ducts | 421 | 2.9 | Hepatocellular carcinoma |
| Bladder | 405 | 3.9 | Bladder & urothelial cancer |
| Prostate | 350 | 10.3 | Prostate cancer |
| Stomach | 278 | 3.0 | Gastric & gastro-oesophageal junction cancer |
| Colorectum | 228 | 2.3 | Colorectal cancer |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
ACTG A5263/AMC 066 NCT01435018 | Phase 3 | Completed | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 11 | 2021-10-20 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Malawi, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Malawi is open is on the registry page, under Contacts and Locations.
OnCo holds no institution, company or person in Malawi.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Malawi is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Malawi is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.